Clinical Trials Browser

Phase 2/3 × Ovarian Neoplasms × masitinib × Clear all

NCT02490488 2020-12-08

Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients

Phase 2/3 Completed

Ovarian Neoplasms